NDAORALCAPSULE, EXTENDED RELEASE2 Generics Approved
Approved
Dec 1991
Lifecycle
LOE Approaching
Competitive Pressure
60/100
Data completeness
3/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CARDIZEM CD is an extended-release oral capsule formulation of diltiazem hydrochloride, a calcium channel blocker used to treat hypertension and angina pectoris. It works by inhibiting calcium influx into vascular smooth muscle and cardiac muscle cells, leading to vasodilation and reduced cardiac workload. The extended-release formulation allows for once-daily dosing, improving patient compliance.
$0.003BPart D
LOE ApproachingDeclining
As LOE approaches, brand teams are consolidating and shifting focus to generic lifecycle management and cost-containment strategies rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Positions on CARDIZEM CD are primarily commercial-facing roles focused on price negotiation, generic defense, and market access rather than growth or innovation. Career growth is limited given the product's LOE status and declining market relevance.
Generic Brand ManagerManaged Care Specialist
Worked on CARDIZEM CD at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.